Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe) (Dialysafe)
Kidney Failure, End Stage Renal Disease, Hypotension
About this trial
This is an interventional prevention trial for Kidney Failure focused on measuring Peer Mentoring, Team Training, Checklist
Eligibility Criteria
Selection is at both the clinic level and individual patient level.
Clinic Inclusion Criteria:
- outpatient hemodialysis facilities
- at least 70 adult (>21 years old) patients to guarantee sample size
Clinic Exclusion Criteria:
- facilities involved in another study
- facilities in immediate jeopardy
- facilities with 1-star quality ratings
- facilities designated as COVID-19 isolation facilities
Individual Patient Exclusion Criteria:
- individual patients who are currently incarcerated
- individual patients who have poor cognition or cognitive impairment
- individual patients unable to comprehend the patient information sheet due to lack of facility in English or Spanish
- individual patients who have opted out of data collection
Sites / Locations
- Fresenius Kidney Care University Of Michigan - Ann Arbor
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
No Intervention
Experimental
Patient Activation
Provider Education
No Intervention
Patient and Provider
This arm focuses on patients. It includes peer mentoring by trained End Stage Renal Disease (ESRD) patients. Mentors will hold 5 multimedia-aided meetings with other patients that include motivational interviewing and role modeling.
This arm focuses on dialysis facility care teams. It includes team training, online education, and checklists.
Patients in clinic receive usual care.
This arm includes both Patient Activation and Provider Education interventions